AD80735
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
1mg | 96% | 2 weeks | $84.00 | $59.00 | - + | |
5mg | 96% | 2 weeks | $253.00 | $177.00 | - + | |
10mg | 96% | 2 weeks | $430.00 | $301.00 | - + | |
25mg | 96% | 2 weeks | $729.00 | $510.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AD80735 |
Chemical Name: | 3-Quinolinecarboxylicacid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(3-oxo-1-piperazinyl)- |
CAS Number: | 103237-52-1 |
Molecular Formula: | C17H16FN3O4 |
Molecular Weight: | 345.325 |
MDL Number: | MFCD04973643 |
SMILES: | O=C1NCCN(C1)c1cc2c(cc1F)c(=O)c(cn2C1CC1)C(=O)O |
1-Cyclopropyl-6-fluoro-4-oxo-7-(3-oxopiperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid, also known as $name$, is a versatile compound commonly used in chemical synthesis. This compound plays a crucial role in the development of novel pharmaceuticals, particularly in the area of antimicrobial agents. Its unique structure and properties make it a valuable building block for the synthesis of various biologically active compounds.In chemical synthesis, $name$ can be utilized as a key intermediate in the creation of potent antibiotics and antimicrobial drugs. Its cyclopropyl and fluoro substituents contribute to enhanced bioavailability and pharmacological activity of the final products. The presence of the piperazine ring also adds to the potential interactions with biological targets, further enhancing the therapeutic potential of the synthesized compounds.Moreover, the carboxylic acid functional group in 1-Cyclopropyl-6-fluoro-4-oxo-7-(3-oxopiperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid allows for easy derivatization, enabling chemists to introduce additional functionalities or modify the compound for specific applications. This flexibility in chemical manipulation makes $name$ a valuable tool in the synthesis of diverse pharmaceutical compounds with tailored properties and activities.